                         SEQUENCE LISTING

<110>  TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED
 
<120>  ANTIMICROBIAL PEPTIDES AND USES THEREOF

<130>  TECH-P-096-PCT

<150>  US62/377,716
<151>  2016-08-22

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Staphylococcus aureus

<400>  1

Leu Phe Lys Phe Phe Lys 
1               5       


<210>  2
<211>  22
<212>  PRT
<213>  Staphylococcus aureus

<400>  2

Met Glu Phe Val Ala Lys Leu Phe Lys Phe Phe Lys Asp Leu Leu Gly 
1               5                   10                  15      


Lys Phe Leu Gly Asn Asn 
            20          


<210>  3
<211>  7
<212>  PRT
<213>  Staphylococcus aureus

<400>  3

Lys Leu Phe Lys Phe Phe Lys 
1               5           


<210>  4
<211>  8
<212>  PRT
<213>  Staphylococcus aureus

<400>  4

Lys Leu Phe Lys Phe Phe Lys Asp 
1               5               


<210>  5
<211>  9
<212>  PRT
<213>  Staphylococcus aureus

<400>  5

Lys Leu Phe Lys Phe Phe Lys Asp Leu 
1               5                   


<210>  6
<211>  10
<212>  PRT
<213>  Staphylococcus aureus

<400>  6

Lys Leu Phe Lys Phe Phe Lys Asp Leu Leu 
1               5                   10  


<210>  7
<211>  11
<212>  PRT
<213>  Staphylococcus aureus

<400>  7

Lys Leu Phe Lys Phe Phe Lys Asp Leu Leu Gly 
1               5                   10      


<210>  8
<211>  13
<212>  PRT
<213>  Staphylococcus aureus

<400>  8

Ala Lys Leu Phe Lys Phe Phe Lys Asp Leu Leu Gly Lys 
1               5                   10              


<210>  9
<211>  16
<212>  PRT
<213>  Staphylococcus aureus

<400>  9

Val Ala Lys Leu Phe Lys Phe Phe Lys Asp Leu Leu Gly Lys Phe Leu 
1               5                   10                  15      


